XML 104 R65.htm IDEA: XBRL DOCUMENT v3.25.1
Segments - Schedule of Expenses by Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
Total research and development expenses $ 71,484 $ 67,829
Total general and administrative expenses 23,693 23,614
Clinical trial-related activities    
Segment Reporting Information [Line Items]    
Total research and development expenses 36,632 32,449
Personnel    
Segment Reporting Information [Line Items]    
Total research and development expenses 19,701 17,276
Total general and administrative expenses 11,367 10,294
Chemistry, manufacturing and control    
Segment Reporting Information [Line Items]    
Total research and development expenses 11,350 14,865
Preclinical studies and activities    
Segment Reporting Information [Line Items]    
Total research and development expenses 1,629 1,267
Professional services    
Segment Reporting Information [Line Items]    
Total general and administrative expenses 4,847 4,469
Consultants and other costs    
Segment Reporting Information [Line Items]    
Total research and development expenses 2,172 1,972
Total general and administrative expenses $ 7,479 $ 8,851